new
adefovir
pmea
prodrug
promoieti
consist
decyl
decyloxyethyl
chain
bear
hydroxyl
function
hexaethyleneglycol
methyl
unit
prepar
start
tetrabutylammonium
salt
phosphon
drug
appropri
alkyl
bromid
tosyl
analog
two
ester
cidofovir
hpmpc
bear
hexaethyleneglycol
moieti
prepar
activ
prodrug
evalu
vitro
differ
viru
famili
loss
antivir
activ
hydroxyl
decyl
decyloxyethyl
ester
hexaethyleneglycol
ester
pmea
human
immunodefici
viru
hiv
herpesvirus
includ
herp
simplex
viru
hsv
varicellazost
viru
vzv
human
cytomegaloviru
cmv
occur
comparison
parent
compound
hand
methyl
ester
pmea
show
signific
activ
hiv
herpesvirus
hpmpc
prodrug
exhibit
anticytomegaloviru
activ
rang
parent
drug
wherea
antihsv
antivzv
activ
oneto
sevenfold
lower
cidofovir
acycl
nucleosid
phosphon
anp
group
compound
remark
antivir
activ
develop
result
three
approv
drug
research
anp
continu
provid
new
activ
compound
presenc
phosphon
group
respons
ionic
charact
subject
physiolog
ph
ioniz
molecul
easili
permeabl
gastrointestin
wall
biolog
membran
order
achiev
better
oral
bioavail
phosphon
group
drug
transform
phosphon
ester
amid
enzymat
cleav
parent
drug
pass
intestin
barrier
later
insid
cell
consider
number
anp
prodrug
evalu
pass
preclin
studi
like
aris
complex
achiev
right
balanc
suitabl
chemic
physic
pharmacolog
prodrug
properti
basic
aim
work
appli
sever
less
common
promoieti
ethyl
adenin
pmea
adefovir
pmea
demonstr
broad
spectrum
antivir
activ
human
immunodefici
viru
hiv
retrovirus
activ
variou
dna
virus
includ
hepat
b
viru
seventeen
herpesvirus
bi
pivaoyloxymethyl
ester
pmea
adefovir
dipivoxyl
bi
pom
pmea
fig
approv
oral
prodrug
treatment
hepat
b
oral
administ
prodrug
absorb
cleav
carboxyesteras
serum
gener
pival
formaldehyd
byproduct
formaldehyd
signific
contributor
overal
cytotox
effect
prodrug
anoth
mask
group
pharmacochemistri
antibioticsth
dioxolenon
unitha
previous
util
mask
carboxyl
function
analog
pivaoyloxymethyl
varieti
howev
rare
exampl
dioxolenon
ester
phosphat
phophon
publish
bioavail
stabil
methyl
ester
explor
methyl
substitu
posit
prove
optim
respect
oral
absorb
well
stabil
prodrug
aim
prepar
conjug
particular
dioxolenon
unit
lipophil
ester
constitut
anoth
import
class
phosphat
phosphon
prodrug
alkyl
alkyloxyalkyl
ester
nucleotid
acycl
nucleosid
phosphon
alreadi
advanc
clinic
studi
antivir
activ
superior
compar
parent
drug
hand
physic
properti
far
optim
suffer
low
solubl
water
addit
simpl
alkyl
chain
subject
xoxid
process
result
inactiv
prodrug
therefor
focus
promoieti
consist
aliphat
chain
modifi
mean
addit
hydroxyl
group
insert
oxygen
atom
hydroxyl
alkyl
alkyloxyalkyl
unit
hexaethyleneglycol
unit
attach
ester
linkag
phosphon
group
adefovir
model
drug
influenc
abovement
modif
vitro
antivir
activ
report
also
studi
effect
addit
hexaethylen
glycol
unit
cidofovir
hpmpc
prodrug
close
relat
cidofovir
hexadecyloxypropyl
octadecyloxyethyl
ester
hdp
hpmpc
ode
hpmpc
respect
fig
hdp
hpmpc
current
develop
use
prophylact
preemptiv
therapi
dsdna
viral
infect
dioxolenon
prodrug
expect
cleav
serum
tissu
esteras
yield
parent
phosphon
carbon
dioxid
rel
nontox
acetoin
accord
scheme
lipid
phosphon
diester
cleav
appropri
monoest
permeat
wall
small
intestin
unlik
dioxolenon
ester
phosphon
lipid
monoest
stabl
plasma
due
hydrolyt
stabil
absenc
phospholipas
remain
ester
linkag
cleav
phosphoesteras
c
insid
cell
believ
role
lipid
promoieti
facilit
passiv
transport
phospholipid
membran
recent
shown
attach
mask
alkyloxyalkyl
unit
phosphon
pharmacophor
affect
pharmacokinet
complexli
prepar
sever
structur
type
pmea
prodrug
outlin
section
see
fig
prodrug
prepar
doublet
correspond
mono
diester
except
compound
present
promoieti
unit
compound
unit
compound
oxi
ethyl
unit
compound
oxi
ethyl
unit
compound
hexaethyleneglycol
unit
compound
methyl
unit
compound
length
hydroxyl
alkyl
chain
compound
limit
access
precursor
hexaethyleneglycol
promoieti
coupl
also
cidofovir
thu
prodrug
prepar
synthesi
prodrug
base
nucleophil
substitut
reaction
acid
poh
group
deproton
neg
charg
oxygen
atom
act
nucleophil
reaction
function
alkyl
bromid
tosyl
prepar
depict
section
tetrabutylammonium
hydroxid
use
base
deproton
alkyl
phosphon
acid
result
tetrabutylammonium
salt
solubl
organ
solvent
react
equiv
appropri
protect
alkyl
bromid
tosyl
moder
yield
acid
labil
protect
group
prepar
phosphon
diester
cleav
subsequ
step
convent
method
acoh
dowex
monoest
prepar
appropri
diester
mean
publish
procedur
involv
treatment
excess
lithium
azid
result
monoest
suffici
stabl
toward
addit
nucleophil
attack
azid
ion
due
presenc
charg
oxygen
atom
phosphon
function
thu
appropri
monoest
isol
sole
product
diisopropylethylamin
util
first
base
prepar
methyl
ester
pmea
monitor
reaction
mixtur
tlc
show
format
rel
nonpolar
product
thought
appropri
diester
howev
disappear
work
reaction
mixtur
monoest
isol
sole
product
see
scheme
although
prepar
procedur
involv
one
equival
tetrabutylammonium
hydroxid
base
seem
suitabl
yield
still
low
cidofovir
alkyl
start
cyclic
form
tetrabutylammonium
salt
treat
tosyl
see
section
result
cyclic
phosphon
ester
yield
monoest
final
work
see
scheme
methyl
bromid
prepar
synthes
accord
publish
procedur
bromid
prepar
prepar
commerci
avail
hydroxyl
group
replac
bromin
doubl
bond
oxid
treatment
osmium
tetroxid
nmethylmorfolinenoxid
scheme
diol
system
protect
isopropyliden
group
prepar
bromid
react
subsequ
step
ethylen
glycol
aris
alcohol
convert
bromid
diol
system
oxid
action
sodium
period
follow
reduct
treatment
momprotect
procedur
result
bromid
treat
twostepway
compound
yield
bromid
bromid
use
alkyl
pmea
accord
scheme
acid
labil
protect
group
isopropyliden
mom
prepar
phosphon
ester
cleav
subsequ
step
convent
method
acoh
dowex
see
scheme
hexaethyleneglycol
moieti
coupl
phosphon
via
monotosyl
hexaethyleneglycol
tosyl
one
equival
tosylchlorid
silver
oxid
base
remain
hydroxyl
group
protect
thp
ether
reaction
prepar
sodium
ethoxid
follow
thp
deprotect
tosyl
threestep
procedur
yield
compound
see
scheme
tosyl
util
pmea
chpmpc
alkyl
see
scheme
thp
protect
group
synthes
phosphon
ester
cleav
presenc
dowex
antivir
activ
differ
compound
evalu
variou
dna
virus
includ
poxvirus
ie
vaccinia
viru
vacv
herpesvirus
ie
herp
simplex
viru
type
type
thymidin
kinasedefici
acyclovirresist
acv
r
varicellazost
viru
vzv
human
cytomegaloviru
hcmv
tabl
compound
also
evalu
retrovirus
ie
human
immunodefici
viru
type
type
tabl
compound
also
examin
sever
rna
virus
includ
vesicular
stomat
viru
vsv
coxsacki
respiratori
syncyti
tabl
none
prodrug
show
activ
differ
rna
virus
except
howev
loss
antivir
activ
hydroxyl
decyl
decyloxyethyl
hexaethyleneglycol
ester
pmea
compound
hiv
observ
sinc
compound
oxi
ethyl
ester
pmea
compound
among
type
prodrug
show
activ
hiv
nontox
concentr
thu
compound
abl
inhibit
hiv
replic
effect
concentr
ec
higher
observ
pmea
contrast
methyl
ester
pmea
antiherpesviru
activ
prodrug
decreas
compar
parent
compound
compound
activ
one
among
prodrug
case
hsv
vzv
drop
antivir
activ
inferior
observ
hiv
sinc
ec
valu
compound
hsv
vzv
threeto
fourfold
lower
pmea
howev
compound
total
inact
cmv
methyl
ester
antiherpesviru
activ
activ
compound
herpesvirus
equival
vzv
two
cmv
fourfold
lower
observ
parent
compound
pmea
ester
pmea
compound
show
weak
activ
vzv
ec
valu
rang
lm
higher
ec
valu
parent
compound
none
pmea
prodrug
show
activ
vaccinia
viru
felin
herpesviru
like
parent
compound
pmea
two
prodrug
hpmpc
compound
ester
phophonomethoxi
propyl
cytosin
ester
phophonomethoxi
propyl
cytosin
abl
inhibit
replic
differ
herpesvirus
test
poxviru
vaccinia
viru
prodrug
activ
equival
hpmpc
cmv
ec
valu
rang
lm
compar
lm
hpmpc
howev
compound
sixto
sevenfold
lower
activ
hpmpc
vzv
compound
activ
hsv
felin
herpesviru
vaccinia
viru
similar
found
hpmpc
activ
compound
virus
lower
alreadi
mention
prodrug
repres
penta
oxyanalog
alkyloxyalkyl
prodrug
develop
hostetl
tabl
compar
antivir
activ
hiv
cmv
analog
simpl
alkoxyalkyl
ester
comparison
demonstr
insert
oxygen
atom
chain
caus
drop
activ
cmv
loss
antihiv
activ
even
signific
fold
compar
hdppmea
comparison
activ
compound
hdppmea
possibl
differ
chain
length
play
role
specul
base
relationship
activ
chain
length
observ
cidofovir
prodrug
adequ
chain
shorten
atom
hdp
atom
octyloxypropyl
caus
circa
drop
anticmv
activ
howev
decreas
antivir
activ
compound
signific
fold
compar
hdppmea
hardli
account
sole
chain
shorten
superior
antivir
activ
hdp
ester
explain
interplay
increas
permeat
cell
membran
bypass
phosphoryl
step
lead
rapid
format
bioactiv
cidofovir
diphosph
sinc
prodrug
less
activ
parent
drug
case
decreas
cellular
uptak
slow
cleavag
promoieti
intracellular
phospholipas
c
may
reason
poor
antivir
activ
set
new
amphiphil
prodrug
pmea
adefovir
hpmpc
cidofovir
prepar
evalu
vitro
phosphon
group
pmea
mask
hexaethyleneglycol
unit
hydroxyl
decyl
decyloxyethyl
chain
first
prodrug
type
appli
also
hpmpc
cidofovir
less
toxic
analog
adefovir
dipivoxyl
methyl
ester
pmea
prepar
howev
complet
mask
phosphon
group
dioxolenon
unit
accomplish
loss
antivir
activ
hexaethyleneglycol
ester
hydroxyl
decyl
decyloxyethyl
ester
pmea
note
methyl
ester
pmea
show
signific
activ
hiv
herpesvirus
hpmpc
prodrug
bear
hexaethyleneglycol
promoieti
exhibit
signific
activ
cytomegaloviru
rang
hpmpc
activ
herpesvirus
poxvirus
oneto
fifteenfold
lower
hpmpc
consid
result
assum
prodrug
taken
less
effici
suitabl
substrat
phospholipas
c
unless
state
otherwis
solvent
evapor
compound
dri
pa
purif
product
revers
phase
hplc
techniqu
perform
water
delta
instrument
water
dual
k
absorb
detector
use
luna
phenomenex
prepar
column
lm
mm
flow
mlmin
elut
condit
given
text
column
chromatographi
perform
lm
silica
gel
fluka
h
c
nmr
spectra
measur
cdcl
dmsod
bruker
avanc
ii
spectromet
h
mhz
c
mhz
bruker
avanc
ii
spectromet
h
mhz
c
mhz
spectra
referenc
tm
dioxan
intern
standard
residu
solvent
signal
dmso
p
nmr
spectra
measur
bruker
avanc
ii
spectromet
mhz
cdcl
use
h
po
extern
standard
gener
number
assign
nmr
signal
depict
figur
mass
spectra
measur
esi
techniqu
use
lcq
fleet
ltq
orbitrap
xl
thermo
fisher
scientif
chemic
ionexchang
resin
purchas
sigmaaldrich
czech
republ
pmea
mg
mmol
suspend
meoh
ml
dissolv
solut
tetrabutylamomonium
hydroxid
ml
solut
meoh
solut
evapor
codistil
isopropanol
ml
toluen
ml
syrupi
residu
dissolv
dmf
ml
appropri
bromid
tosyl
mmol
ad
mixtur
stir
h
evapor
residu
chromatograph
silica
gel
column
g
meohchcl
compound
meohchcl
other
compound
prepar
gener
procedur
reflux
methanol
hydrochlor
acid
ml
ph
h
mixtur
evapor
codistil
ethanol
crystal
etohet
yield
mg
crystal
mp
ester
prepar
gener
procedur
contamin
tetrabutylammonium
salt
mixtur
treat
dowex
h
methanol
suspens
put
dowex
h
column
rins
water
follow
ammonia
uvadsorb
eluat
evapor
yield
mg
syrup
product
obtain
accord
gener
procedur
use
tosyl
contamin
tetrabutylammonium
bromid
purifi
dowex
h
column
ml
rins
water
follow
elut
ammonia
uvabsorb
fraction
evapor
codistil
ethanol
toluen
yield
mg
syrup
appropri
diester
mmol
lin
mg
mmol
dmf
ml
heat
convers
monitor
mean
tlc
chcl
meoh
convers
complet
h
product
crystal
overnight
reaction
mixtur
recrystal
h
oetoh
afford
mg
mp
cyclic
hpmpc
mg
mmol
prepar
accord
lit
suspend
meoh
ml
dissolv
solut
tetrabutylamomonium
hydroxid
ml
solut
meoh
solut
evapor
codistil
isopropanol
ml
toluen
ml
syrupi
residu
dissolv
dmf
ml
appropri
tosyl
mmol
ad
mixtur
stir
h
evapor
residu
chromatograph
silica
gel
column
g
meohchcl
obtain
cyclic
ester
hpmpc
contamin
tetrabutylammonium
salt
ester
phophonomethoxi
propyl
cytosin
crude
ester
prepar
gener
procedur
heat
aqueou
acet
acid
ml
h
mixtur
evapor
codistil
h
residu
deioniz
dowex
h
column
ml
rins
water
follow
ammonia
uvadsorb
eluat
concentr
put
dowex
aco
column
ml
column
wash
water
product
elut
aqueou
acoh
uvadsorb
fraction
evapor
codistil
water
ethanol
toluen
yield
mg
syrup
crude
ester
prepar
gener
procedur
deioniz
dowex
h
column
ml
gradient
water
ammonia
concentr
uvadsorb
eluat
put
dowex
aco
ml
gradient
water
acet
acid
yield
mg
syrup
triphenylphosphin
g
mmol
ad
sever
portion
cool
solut
mmol
cbr
mmol
g
dichloromethan
ml
reaction
mixtur
stir
h
h
room
temperatur
subsequ
evapor
residu
filter
short
silica
gel
column
cm
hexan
mobil
phase
eluat
evapor
crude
bromid
dissolv
aceton
ml
nmethylmorpholin
noxid
ml
aqueou
solut
mmol
osmium
tetroxid
g
aqueou
solut
ad
reaction
mixtur
stir
h
room
temperatur
concentr
ml
partit
ether
ml
aqueou
solut
sodium
thiosulf
ml
aqueou
layer
wash
ether
ml
combin
ether
portion
dri
mgso
filter
evapor
residu
purifi
short
silica
gel
column
cm
ethyl
acetatehexan
fraction
evapor
product
crystal
toluenehexan
yield
g
g
diol
g
mmol
ml
treat
toluenesulfon
acid
mg
mmol
room
temperatur
min
solut
extract
aqueou
solut
nahco
ml
aqueou
solut
wash
ether
ml
combin
organ
fraction
dri
mgso
evapor
crude
product
g
use
next
step
without
purif
ethyleneglycol
l
mmol
slowli
ad
cool
suspens
nah
mg
suspens
miner
oil
mmol
dri
dmf
ml
suspens
stir
overnight
room
temperatur
bromid
g
mmol
dmf
ml
ad
mixtur
stir
h
excess
nah
decompos
sever
drop
meoh
solvent
evapor
residu
partit
chloroform
ml
water
ml
aqueou
layer
treat
water
combin
organ
extract
dri
mgso
evapor
residu
chromatograph
silica
gel
column
g
acetonhexan
fraction
contain
main
product
evapor
syrupi
residu
g
dissolv
dichloromethan
ml
cbr
g
mmol
ad
solut
cool
triphenylphosphin
g
mmol
ad
reaction
mixtur
stir
h
h
room
temperatur
subsequ
evapor
residu
chromatograph
silica
gel
column
acetonehexan
yield
g
liquid
solut
diol
g
mmol
thfh
ml
cool
naio
g
mmol
ad
stir
nabh
g
mmol
ad
h
later
reaction
mixtur
stir
overnight
room
temperatur
concentr
ml
aqueou
residu
extract
etoac
ml
combin
organ
layer
dri
mgso
evapor
residu
dissolv
ch
cl
ml
solut
cool
treat
ipr
etn
ml
mmol
methoxymethyl
bromid
ml
mmol
solut
allow
heat
room
temperatur
stir
overnight
mixtur
wash
aqueou
solut
nahco
ml
dichloromethan
portion
dri
mgso
evapor
residu
chromatograph
compound
antivir
activ
express
ec
concentr
requir
reduc
virusinduc
cytopathogen
viral
plaqu
format
methodolog
antihiv
assay
follow
human
cem
cellscm
infect
ccid
iiib
rod
ml
seed
well
microtit
plate
contain
appropri
dilut
test
compound
four
day
incub
hivinduc
cem
giant
cell
format
examin
microscop
cytotox
measur
base
inhibit
cell
growth
hel
cell
seed
rate
cellswel
microtit
plate
allow
prolifer
h
medium
contain
differ
concentr
test
compound
ad
three
day
incub
cell
number
determin
coulter
counter
cytostat
concentr
calcul
cc
compound
concentr
requir
reduc
cell
prolifer
rel
number
cell
untreat
control
cc
valu
estim
graphic
plot
number
cell
percentag
control
function
concentr
test
compound
altern
cytotox
test
compound
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
